Bath & Body Works (NYSE:BBWI) Releases Q3 Earnings Guidance

Bath & Body Works (NYSE:BBWI) issued an update on its third quarter earnings guidance on Wednesday morning. The company provided EPS guidance of $0.41-0.47 for the period, compared to the consensus EPS estimate of $0.47. The company issued revenue guidance of flat to +2.5% yr/yr to ~$1.56-1.60 billion, compared to the consensus revenue estimate of $1.58 billion. Bath & Body Works also updated its FY25 guidance to $3.06-3.26 EPS.

Bath & Body Works Stock Up 4.0 %

Shares of NYSE BBWI opened at $31.74 on Friday. The firm has a market cap of $6.95 billion, a price-to-earnings ratio of 8.18, a price-to-earnings-growth ratio of 0.96 and a beta of 1.77. The company’s 50-day simple moving average is $31.96 and its 200-day simple moving average is $40.40. Bath & Body Works has a 52-week low of $26.20 and a 52-week high of $52.99.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.02. The company had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. Equities research analysts anticipate that Bath & Body Works will post 3.18 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Friday, August 23rd were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.52%. The ex-dividend date was Friday, August 23rd. Bath & Body Works’s dividend payout ratio (DPR) is presently 20.62%.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Telsey Advisory Group reaffirmed an outperform rating and set a $42.00 target price on shares of Bath & Body Works in a research note on Thursday. Robert W. Baird decreased their price objective on Bath & Body Works from $54.00 to $45.00 and set an outperform rating on the stock in a report on Thursday, August 29th. Citigroup lowered their price objective on Bath & Body Works from $48.00 to $35.00 and set a neutral rating for the company in a research report on Tuesday, August 20th. Evercore ISI reduced their target price on Bath & Body Works from $45.00 to $35.00 and set an in-line rating on the stock in a research report on Wednesday, August 28th. Finally, The Goldman Sachs Group lowered their price target on Bath & Body Works from $60.00 to $49.00 and set a buy rating for the company in a report on Thursday, August 29th. Eight equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, Bath & Body Works presently has a consensus rating of Moderate Buy and an average target price of $42.35.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.